Company profile

BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis. Through its single cell whole genome and whole transcriptome amplification tools, scientists and clinicians can gain an unprecedented view of the genome and transcriptome, within a single cell to better understand the drivers, mechanisms, and management of complex disease.

BioSkryb’s ResolveDNA genome amplification technology enables researchers to accurately examine whole genomes or whole exomes from single cells, or low-input DNA samples to reveal novel insights on the molecular drivers of disease. ResolveDNA reduces biases, experimental artifacts, and poor reproducibility that are commonly associated with traditional amplification methods, resulting in increased genomic coverage at an unprecedented resolution. ResolveOME is a first of its kind multiomic solution that combines whole genome or exome analysis with whole transcriptome analysis within each individual cell in an integrated workflow and can help investigators explore complex multiomic datasets at scale. Powered by BioSkryb’s patented primary template-directed amplification (PTA) technology, ResolveOME and ResolveDNA dramatically increase genomic coverage to 97%. When coupled with BioSkryb’s BaseJumper™ bioinformatics platform, which provides quick analysis of complex data at scale, investigators can comprehensively explore single cell multiomic data to enhance understanding of complex diseases.

 

 

Let Every Single Cell Tell Its Story!

 

Learn more about BioSkryb

 

Read the Press Release